Björn Dahlbäck
171 – 180 of 278
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Altered inactivation pathway of factor Va by activated protein C in the presence of heparin
(
- Contribution to journal › Article
-
Mark
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?
(
- Contribution to journal › Scientific review
-
Mark
Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts.
(
- Contribution to journal › Article
- 2003
-
Mark
Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
(
- Contribution to journal › Article
-
Mark
Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.
(
- Contribution to journal › Article
-
Mark
Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
(
- Contribution to journal › Article
-
Mark
The discovery of activated protein C resistance.
(
- Contribution to journal › Article
-
Mark
Molecular recognition in the protein C anticoagulant pathway.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein (C4BP) activates B cells through the CD40 receptor
(
- Contribution to journal › Article
-
Mark
Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma.
(
- Contribution to journal › Article